HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro” or the “Company,” Pink Sheets: TAROF) today reported that it received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (“ANDA”) for Fluorouracil Topical Cream USP, 5% (“fluorouracil cream”).
